Adverse Outcomes Associated with Systemic Glucocorticoids: Dose–Time Effects in Real-World Inflammatory Disease Cohorts covering 3.7 million patients
Authors 20
-
Michael Dreher Aachen
Affiliation as printed
RWTH Aachen University
-
Julian Witte corresponding
Affiliation as printed
Vandage GmbH
Vandage GmbH, Bielefeld, Germany
-
Affiliation as printed
University of Münster
-
Affiliation as printed
Municipal Hospital Braunschweig
-
Medizinische Hochschule Hannover
Affiliation as printed
Hannover Medical School
Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, 30625, Germany
-
Affiliation as printed
University Clinic Frankfurt
-
Affiliation as printed
Vandage GmbH
-
Affiliation as printed
Vandage GmbH
-
Affiliation as printed
BARMER
-
Affiliation as printed
GlaxoSmithKline - Munich
-
Affiliation as printed
GlaxoSmithKline - Munich
-
Affiliation as printed
GlaxoSmithKline - Munich
-
Charité - Universitätsmedizin Berlin
Affiliation as printed
Charité - Universitätsmedizin Berlin
-
Affiliation as printed
University of Heidelberg
-
Christian-Albrechts-Universität zu Kiel
Affiliation as printed
University of Kiel
-
Flurin Müller-Diesing Aachen
Affiliation as printed
RWTH Aachen University
-
Affiliation as printed
University of Wuerzburg - University Hospital of Wuerzburg
-
Universität Hamburg · University Medical Center Hamburg-Eppendorf
Affiliation as printed
University of Hamburg - University Medical Center Hamburg-Eppendorf
-
Affiliation as printed
Immanuel Krankenhaus Berlin
-
Charité - Universitätsmedizin Berlin
Affiliation as printed
Charité - Universitätsmedizin Berlin
Cited by 0 stored of 0
No patents citing this paper on Lens.org (checked 2026-10-06).